Search

everythinglearnresearchcommunity

for

Search:↓

Reassurance and counseling are key in managing acute telogen effluvium, with supplements possibly offering a placebo effect.

Some people may temporarily lose more hair in certain areas after a hair transplant.

Iron deficiency common in women, not always linked to hair loss; more research needed.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Woman's hair loss diagnosis changed from CTE to AA; multiple biopsies important for accurate diagnosis.

Washing test helps identify hair loss type, low iron levels significant.

Telogen effluvium is a hair loss condition caused by various factors and requires a thorough examination to diagnose and differentiate from other hair loss types.

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

Shorter, thinner hairs indicate AGA, while longer, thicker hairs suggest CTE; counting and measuring shed hairs helps diagnose hair loss type.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

ATE is linked to FAA, and treatment depends on cause; minoxidil helps, finasteride may worsen.

Emotional stress can trigger intermittent hair loss in chronic telogen effluvium, which may not improve with treatment if stress continues.

The article suggests that the belief in common postpartum hair loss lacks sufficient evidence and may be overestimated.

Certain gene variations in the Vitamin D receptor may increase the risk of chronic hair loss.

Low ferritin and zinc levels, as well as anemia, are linked to more severe hair loss in Egyptian children with chronic hair shedding.

Iron deficiency is linked to hair loss in CTE patients.

People with chronic hair loss may have a higher chance of Vitamin B12 deficiency.

A patient experienced intense hair loss due to telogen effluvium after scalp contact dermatitis, but hair regrew completely within two months without further treatment.

CTE and FPHL are different hair loss types with unique causes.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Low serum ferritin levels are not closely linked to telogen effluvium in women.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Women with telogen effluvium have lower levels of iron, folate, and vitamin B12.

Hair loss in Cronkhite-Canada syndrome may be caused by autoimmune factors, not just stress or malabsorption.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

COVID-19 may cause hair loss due to infection stress or treatments.

Oral minoxidil effectively reduces hair shedding in women with CTE, with no major side effects.

A dietary supplement with Boswellia serrata, Curcuma longa, and Vitis vinifera showed potential improvement in hair health for telogen effluvium patients, but more research is needed.

One supplement improved hair loss and quality faster and more effectively than the other in treating telogen effluvium.

A woman's hair loss after COVID-19 was likely due to a mix of pressure-induced alopecia and acute telogen effluvium.